Acute and chronic stress-induced disturbances of microglial plasticity, phenotype and function

Current Drug Targets

Volumn 14, Issue 11, 2013, Pages 1262-1276

  Walker, Frederick Rohan ^a   Nilsson, Michael ^a   Jones, Kimberley ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Acute stress; Chronic stress; Depression; Glia; Inflammation; Microglia; Mood disturbance; Neuroinflammation; Neuroplasticity; Remodelling

Indexed keywords

ADRENALIN; ATOMOXETINE; CD11B ANTIGEN; CD68 ANTIGEN; CORTICOSTERONE; CYTOKINE; DESIPRAMINE; DOBUTAMINE; INTERLEUKIN 1BETA; ISOPRENALINE; LOW DENSITY LIPOPROTEIN; MINOCYCLINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; NORADRENALIN; PHORBOL 13 ACETATE 12 MYRISTATE; TERBUTALINE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ACUTE STRESS; ANTIBODY LABELING; CHRONIC STRESS; COGNITION; EMOTIONALITY; HOMEOSTASIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREACTIVITY; IMMUNOSTIMULATION; MICROGLIA; NERVE CELL PLASTICITY; NERVE DEGENERATION; PHAGOCYTOSIS; REVIEW;

ACUTE DISEASE; ANIMALS; BRAIN; CHRONIC DISEASE; HUMANS; INFLAMMATION; MICROGLIA; MOOD DISORDERS; NEURONAL PLASTICITY; PHENOTYPE; STRESS, PSYCHOLOGICAL;

EID: 84887962377     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/13894501113149990208     Document Type: Review

References (102)

1. Hammen C. Stress and depression. Annu Rev Clin Psychol 2005; 1: 293-319.
2. McEwen BS. The neurobiology of stress: from serendipity to clinical relevance. Brain Res 2000; 886(1-2): 172-89.
3. Winsky-Sommerer R, Yamanaka A, Diano S, et al. Interaction between the Corticotropin-Releasing Factor System and Hypocretins (Orexins): A Novel Circuit Mediating Stress Response. J Neurosci 2004; 24(50): 11439-48.
4. Vyas A, Mitra R, Rao BS, Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 2002; 22(15): 6810-8.
5. Shansky RM, Morrison JH. Stress-induced dendritic remodeling in the medial prefrontal cortex: Effects of circuit, hormones and rest. Brain Res 2009; 1293(0): 108-13.
6. Hinwood M, Tynan RJ, Charnley JL, Beynon SB, Day TA, Walker FR. Chronic Stress Induced Remodeling of the Prefrontal Cortex: Structural Re-Organization of Microglia and the Inhibitory Effect of Minocycline. Cereb Cortex 2013; 23(8): 1784-97.
7. Tynan RJ, Naicker S, Hinwood M, et al. Chronic stress alters the density and morphology of microglia in a subset of stressresponsive brain regions. Brain Behav Immun 2010; 24(7): 1058-68.
8. Jauregui-Huerta F, Ruvalcaba-Delgadillo Y, Gonzalez-Castañeda R, Garcia-Estrada J, Gonzalez-Perez O, Luquin S. Responses of glial cells to stress and glucocorticoids. Curr Immunol Rev 2010; 6(3): 195.
9. Graeber M, Streit W. Microglia: biology and pathology. Acta Neuropathol 2010; 119(1): 89-105.
10. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 2009; 29(13): 3974-80.
11. Day TA. Defining stress as a prelude to mapping its neurocircuitry: no help from allostasis. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29(8): 1195-200.
12. Koolhaas JM, Bartolomucci A, Buwalda B, et al. Stress revisited: a critical evaluation of the stress concept. Neurosci Biobehav Rev 2011; 35(5): 1291-301.
13. Day TA, Walker FR. More appraisal please: a commentary on Pfaff et al. (2007) Relations between mechanisms of CNS arousal and mechanisms of stress. Stress 2007; 10(4): 311-3; discussion 4-5.
14. Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 2009; 10(6): 397-409.
15. Walker F, Nalivaiko E, Day TA. Stress an Inflammation: An Emerging Story. In: Garg ML, Vood, LG, editor. Nutrition & Physical Activity in Inflammatory Diseases: Cab International; 2013.
16. Checkley S. The neuroendocrinology of depression and chronic stress. Br Med Bull 1996; 52(3): 597-617.
17. Tremblay M-È, Stevens B, Sierra A, et al. The Role of Microglia in the Healthy Brain. J Neurosci 2011; 31(45): 16064-9.
18. Lawson LJ, Perry VH, Dri P, Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990; 39(1): 151-70.
19. Mittelbronn M, Dietz K, Schluesener H, Meyermann R. Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude. Acta Neuropathol (Berl) 2001; 101(3): 249-55.
20. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005; 308(5726): 1314-8.
21. Davalos D, Grutzendler J, Yang G, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005; 8(6): 752-8.
22. Tremblay M-È, Lowery RL, Majewska AK. Microglial Interactions with Synapses Are Modulated by Visual Experience. PLoS Biol 2010; 8(11): e1000527.
23. Imamura K, Hishikawa N, Sawada M, et al. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta neuropathologica 2003; 106(6): 518-26.
24. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends in Neurosciences 1996; 19(8): 312-8.
25. Streit WJ, Mrak RE, Griffin WST. Microglia and neuroinflammation: A pathological perspective. J Neuroinflammation 2004; 1: 14.
26. Liu B, Hong J-S. Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention. J Pharmacol Exp Ther 2003; 304(1): 1-7.
27. Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993; 81(6): 1607-13.
28. Streit WJ, Graeber MB, Kreutzberg GW. Peripheral nerve lesion produces increased levels of major histocompatibility complex antigens in the central nervous system. J Neuroimmunol 1989; 21(2): 117-23.
29. Stence N, Waite M, Dailey ME. Dynamics of microglial activation: A confocal time-lapse analysis in hippocampal slices. Glia 2001; 33(3): 256-66.
30. Beynon SB, Walker FR. Microglial activation in the injured and healthy brain: What are we really talking about? Practical and theoretical issues associated with the measurement of changes in microglial morphology. Neuroscience 2012; 225(0): 162-71.
31. Sugama S, Fujita M, Hashimoto M, Conti B. Stress induced morphological microglial activation in the rodent brain: involvement of interleukin-18. Neuroscience 2007; 146(3): 1388-99.
32. Fontainhas AM, Wang M, Liang KJ, et al. Microglial Morphology and Dynamic Behavior Is Regulated by Ionotropic Glutamatergic and GABAergic Neurotransmission. PLoS ONE 2011; 6(1): e15973.
33. Davis EJ, Foster TD, Thomas WE. Cellular forms and functions of brain microglia. Brain Res Bull 1994; 34(1): 73-8.
34. Kettenmann H, Hanisch U-K, Noda M, Verkhratsky A. Physiology of Microglia. Physiol Rev 2011; 91(2): 461-553.
35. Streit WJ, Walter SA, Pennell NA. Reactive microgliosis. Prog Neurobiol 1999; 57(6): 563-81.
36. Stence N, Waite M, Dailey ME. Dynamics of microglial activation: A confocal time-lapse analysis in hippocampal slices. Glia 2001; 33(3): 256-66.
37. Wilson MA, Molliver ME. Microglial response to degeneration of serotonergic axon terminals. Glia 1994; 11(1): 18-34.
38. O'Connor KA, Hansen MK, Rachal Pugh C, et al. Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects. Cytokine 2003; 24(6): 254-65.
39. Blandino Jr P, Barnum CJ, Deak T. The involvement of norepinephrine and microglia in hypothalamic and splenic IL-1 β responses to stress. J Neuroimmunol 2006; 173(1): 87-95.
40. Tikka T, Fiebich BL, Goldsteins G, Keinänen R, Koistinaho J. Minocycline, a Tetracycline Derivative, Is Neuroprotective against Excitotoxicity by Inhibiting Activation and Proliferation of Microglia. J Neurosci 2001; 21(8): 2580-8.
41. Shimoda M, Jones VC, Kobayashi M, Suzuki F. Microglial cells from psychologically stressed mice as an accelerator of cerebral cryptococcosis. Immunol Cell Biol 2006; 84(6): 551-6.
42. De Pablos R, Villaran R, Argüelles S, et al. Stress increases vulnerability to inflammation in the rat prefrontal cortex. J Neurosci 2006; 26(21): 5709-19.
43. Nair A, Bonneau RH. Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J Neuroimmunol 2006; 171(1): 72-85.
44. Sugama S, Takenouchi T, Fujita M, Kitani H, Hashimoto M. Cold stress induced morphological microglial activation and increased IL-1 β expression in astroglial cells in rat brain. J Neuroimmunol 2011; 233(1): 29-36.
45. Frank MG, Baratta MV, Sprunger DB, Watkins LR, Maier SF. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun 2007; 21(1): 47-59.
46. Johnson JD, O'Connor KA, Deak T, et al. Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav Immun 2002; 16(4): 461-76.
47. Hinwood M, Morandini J, Day TA, Walker FR. Evidence that Microglia Mediate the Neurobiological Effects of Chronic Psychological Stress on the Medial Prefrontal Cortex. Cereb Cortex 2012; 22(6): 1442-54.
48. Wohleb ES, Hanke ML, Corona AW, et al. β -Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J Neurosci 2011; 31(17): 6277-88.
49. Burguillos MA, Deierborg T, Kavanagh E, et al. Caspase signalling controls microglia activation and neurotoxicity. Nature 2011; 472(7343): 319-24.
50. Beynon SB, Walker FR. Microglial activation in the injured and healthy brain: what are we really talking about? Practical and theoretical issues associated with the measurement of changes in microglial morphology. Neuroscience 2012.
51. Bian Y, Pan Z, Hou Z, et al. Learning, memory, and glial cell changes following recovery from chronic unpredictable stress. Brain Res Bull 2012.
52. Couch Y, Anthony DC, Dolgov O, et al. Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia. Brain Behav Immun 2013; 29: 136-46.
53. Farooq RK, Isingrini E, Tanti A, et al. Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation? Behav Brain Res 2012.
54. Kopp BL, Wick D, Herman JP. Differential Effects of Homotypic vs. Heterotypic Chronic Stress Regimens on Microglial Activation in the Prefrontal Cortex. Physiol Behav 2013.
55. Sugama S, Takenouchi T, Fujita M, et al. Corticosteroids limit microglial activation occurring during acute stress. Neuroscience 2013; 232(0): 13-20.
56. Sugama S, Takenouchi T, Fujita M, Conti B, Hashimoto M. Differential microglial activation between acute stress and lipopolysaccharide treatment. J Neuroimmunol 2009; 207(1): 24-31.
57. Blandino Jr P, Barnum CJ, Solomon LG, et al. Gene expression changes in the hypothalamus provide evidence for regionallyselective changes in IL-1 and microglial markers after acute stress. Brain Behav Immun 2009; 23(7): 958-68.
58. Frank MG, Miguel ZD, Watkins LR, Maier SF. Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide. Brain Behav Immun 2010; 24(1): 19-30.
59. Frank MG, Thompson BM, Watkins LR, Maier SF. Glucocorticoids mediate stress-induced priming of microglial proinflammatory responses. Brain Behav Immun 2012; 26(2): 337-45.
60. Wohleb ES, Fenn AM, Pacenta AM, et al. Peripheral innate immune challenge exaggerated microglia activation, increased the number of inflammatory CNS macrophages, and prolonged social withdrawal in socially defeated mice. Psychoneuroendocrinology 2012; 37(9): 1491-505.
61. Bradesi S, Svensson CI, Steinauer J, et al. Role of spinal microglia in visceral hyperalgesia and NK1R up-regulation in a rat model of chronic stress. Gastroenterology 2009; 136(4): 1339-48. e2.
62. Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 1997; 20(2): 78-84.
63. Herman JP, Ostrander MM, Mueller NK, Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitaryadrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29(8): 1201-13.
64. Sierra A, Gottfried-Blackmore A, Milner TA, McEwen BS, Bulloch K. Steroid hormone receptor expression and function in microglia. Glia 2008; 56(6): 659-74.
65. Tanaka J, Fujita H, Matsuda S, et al. Glucocorticoid-and mineralocorticoid receptors in microglial cells: The two receptors mediate differential effects of corticosteroids. Glia 1997; 20(1): 23-37.
66. Hwang IK, Yoo K-Y, Nam YS, et al. Mineralocorticoid and glucocorticoid receptor expressions in astrocytes and microglia in the gerbil hippocampal CA1 region after ischemic insult. Neurosci Res 2006; 54(4): 319-27.
67. Woods A, Poulsen F, Gall C. Dexamethasone selectively suppresses microglial trophic responses to hippocampal deafferentation. Neuroscience 1999; 91(4): 1277-89.
68. Zhang Z, Zhang Z, Artelt M, Burnet M, Schluesener HJ. Dexamethasone attenuates early expression of three molecules associated with microglia/macrophages activation following rat traumatic brain injury. Acta Neuropathol 2007; 113(6): 675-82.
69. Jacobsson J, Persson M, Hansson E, Rönnbäck L. Corticosterone inhibits expression of the microglial glutamate transporter GLT-1 in vitro. Neuroscience 2006; 139(2): 475-83.
70. Graber DJ, Hickey WF, Stommel EW, Harris BT. Antiinflammatory efficacy of dexamethasone and Nrf2 activators in the CNS using brain slices as a model of acute injury. J Neuroimmune Pharmacol 2012; 7(1): 266-78.
71. Hinkerohe D, Smikalla D, Schoebel A, et al. Dexamethasone prevents LPS-induced microglial activation and astroglial impairment in an experimental bacterial meningitis co-culture model. Brain Res 2010; 1329: 45-54.
72. Alexander JK, DeVries AC, Kigerl KA, Dahlman JM, Popovich PG. Stress exacerbates neuropathic pain via glucocorticoid and NMDA receptor activation. Brain Behav Immun 2009; 23(6): 851-60.
73. Yoo K-Y, Lee CH, Choi JH, et al. Changes in corticosteroid hormone receptors in the ischemic gerbil hippocampal CA1 region following repeated restraint stress. Neurochem Res 2011; 36(5): 701-12.
74. Giovanoli S, Engler H, Engler A, et al. Stress in Puberty Unmasks Latent Neuropathological Consequences of Prenatal Immune Activation in Mice. Science 2013; 339(6123): 1095-9.
75. Espinosa-Oliva A, de Pablos R, Villarán R, et al. Stress is critical for LPS-induced activation of microglia and damage in the rat hippocampus. Neurobiol Aging 2011; 32(1): 85-102.
76. Frank MG, Watkins LR, Maier SF. Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger. Brain Behav Immun 2013.
77. Johnson JD, Zimomra ZR, Stewart LT. Beta-adrenergic receptor activation primes microglia cytokine production. J Neuroimmunol 2013; 254(1-2): 161-4.
78. Johnson JD, Zimomra ZR, Stewart LT. Beta-adrenergic receptor activation primes microglia cytokine production. J Neuroimmunol 2012.
79. Chao CC, Hu S, Close K, et al. Cytokine Release from Microglia: Differential Inhibition by Pentoxifylline and Dexamethasone. The Journal of Infectious Diseases. 1992; 166(4): 847-53.
80. Mori K, Ozaki E, Zhang B, et al. Effects of norepinephrine on rat cultured microglial cells that express α1, &alpha2, β1 and β2 adrenergic receptors. Neuropharmacology 2002; 43(6): 1026-34.
81. Johnson JD, Campisi J, Sharkey CM, et al. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 2005; 135(4): 1295-307.
82. McNamee EN, Ryan KM, Griffin EW, et al. Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration. Brain Behav Immun 2010; 24(4): 660-71.
83. Pinteaux E, Parker LC, Rothwell NJ, Luheshi GN. Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J Neurochem 2002; 83(4): 754-63.
84. Colton CA, Chernyshev ON. Inhibition of microglial superoxide anion production by isoproterenol and dexamethasone. Neurochem Int 1996; 29(1): 43-53.
85. Dello Russo C, Boullerne AI, Gavrilyuk V, Feinstein DL. Inhibition of microglial inflammatory responses by norepinephrine: Effects on nitric oxide and interleukin-I β production. J Neuroinflammation 2004; 1.
86. Färber K, Pannasch U, Kettenmann H. Dopamine and noradrenaline control distinct functions in rodent microglial cells. Mol Cell Neurosci 2005; 29(1): 128-38.
87. Tynan RJ, Weidenhofer J, Hinwood M, et al. A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun 2012; 26(3): 469-79.
88. O'Sullivan JB, Ryan KM, Curtin NM, Harkin A, Connor TJ. Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: Implications for depression and neurodegeneration. Int J Neuropsychopharmacol 2009; 12(5): 687-99.
89. Hwang J, Zheng LT, Ock J, et al. Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology 2008; 55(5): 826-34.
90. O'Sullivan JB, Ryan KM, Curtin NM, Harkin A, Connor TJ. Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. Int J Neuropsychopharmacol 2009; 12(05): 687-99.
91. Hashioka S, Klegeris A, Monji A, et al. Antidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxide. Exp Neurol 2007; 206(1): 33-42.
92. Tan KS, Nackley AG, Satterfield K, et al. β 2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA-and NF-κBindependent mechanisms. Cell Signal 2007; 19(2): 251-60.
93. Wall EA, Zavzavadjian JR, Chang MS, et al. Suppression of LPSInduced TNF-{alpha} Production in Macrophages by cAMP Is Mediated by PKA-AKAP95-p105. Sci Signal 2009; 2(75): ra28.
94. Min K-J, Yang M-S, Kim S-U, Jou I, Joe E-H. Astrocytes Induce Hemeoxygenase-1 Expression in Microglia: A Feasible Mechanism for Preventing Excessive Brain Inflammation. J Neurosci 2006; 26(6): 1880-7.
95. Röhl C, Armbrust E, Kolbe K, et al. Activated microglia modulate astroglial enzymes involved in oxidative and inflammatory stress and increase the resistance of astrocytes to oxidative stress in vitro. Glia 2008; 56(10): 1114-26.
96. Czéh B, Simon M, Schmelting B, Hiemke C, Fuchs E. Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 2005; 31(8): 1616-26.
97. Tynan RJ, Beynon SB, Hinwood M, et al. Chronic stress-induced disruption of the astrocyte network is driven by structural atrophy and not loss of astrocytes. Acta neuropathologica 2013: 1-17.
98. Aarum J, Sandberg K, Haeberlein SLB, Persson MAA. Migration and differentiation of neural precursor cells can be directed by microglia. Proc Natl Acad Sci USA 2003; 100(26): 15983-8.
99. Butovsky O, Ziv Y, Schwartz A, et al. Microglia activated by IL-4 or IFN-γ differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci 2006; 31(1): 149-60.
100. Battista D, Ferrari CC, Gage FH, Pitossi FJ. Neurogenic niche modulation by activated microglia: transforming growth factor β increases neurogenesis in the adult dentate gyrus. Eur J Neurosci 2006; 23(1): 83-93.
101. Bolo NR, Hodé Y, Nédélec J-F, et al. Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy. Neuropsychopharmacology 2000; 23(4): 428-38.
102. Henry ME, Schmidt ME, Hennen J, et al. A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: a 19-F MRS study. Neuropsychopharmacology 2005; 30(8): 1576-83.